Shopping Cart
Remove All
Your shopping cart is currently empty
(S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 500 μg | $246 | 35 days | 35 days | |
| 1 mg | $468 | 35 days | 35 days | |
| 5 mg | $1,920 | 35 days | 35 days | |
| 10 mg | $3,390 | 35 days | 35 days |
| Description | (S)-p38 MAPK inhibitor III is a methylsulfanylimidazole that inhibits p38 MAP kinase (IC50 = 0.90 μM in vitro). It is cell-permeable, potently blocking the release of TNF-α and IL-1β from human peripheral blood mononuclear cells (IC50s = 0.37 and 0.044 μM, respectively). |
| Targets&IC50 | p38 MAPk:0.9 μM |
| Synonyms | (S)-p38 MAPK Inhibitor III |
| Molecular Weight | 404.5 |
| Formula | C23H21FN4S |
| Cas No. | 581098-48-8 |
| Relative Density. | 1.30 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 12 mg/mL (29.67 mM), Sonication is recommended. Ethanol: 30 mg/mL (74.17 mM), Sonication is recommended. Ethanol:PBS (pH 7.2)(1:2): 0.33 mg/mL (0.82 mM), Sonication is recommended. DMF: 20 mg/mL (49.44 mM), Sonication is recommended. |
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (2.47 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.